CIK 0001099800 · Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364316614
- Phone
- 9492502500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +619 | $72.68 | $45K | 40,652.91 |
| 2026-11-10 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −619 | $104.25 | $65K | 40,033.91 |
| 2026-11-10 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 2,476 | ||
| 2026-10-08 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +619 | $72.68 | $45K | 40,652.91 |
| 2026-10-08 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −619 | $85.65 | $53K | 40,033.91 |
| 2026-10-08 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 3,095 | ||
| 2026-09-11 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +619 | $72.68 | $45K | 40,652.91 |
| 2026-09-11 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −619 | $87.51 | $54K | 40,033.91 |
| 2026-09-11 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 3,714 | ||
| 2026-08-11 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +619 | $72.68 | $45K | 40,652.91 |
| 2026-08-11 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −619 | $92.03 | $57K | 40,033.91 |
| 2026-08-11 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 4,333 | ||
| 2026-07-10 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +619 | $72.68 | $45K | 40,652.91 |
| 2026-07-10 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −619 | $91.70 | $57K | 40,033.91 |
| 2026-07-10 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 4,952 | ||
| 2026-07-07 | Lippis Daniel J. CVP, TAVR | Shares withheld for taxes | −377 | $95.18 | $36K | 40,033.91 |
| 2026-06-30 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +619 | $72.68 | $45K | 41,029.91 |
| 2026-06-30 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −619 | $91.40 | $57K | 40,410.91 |
| 2026-06-30 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −619 | 5,571 | ||
| 2026-05-18 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +620 | $72.68 | $45K | 41,030.91 |
Page 1 of 3 · 58 trades